Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
48.25M | 160.00K | 80.20M | 189.94M | 113.68M | Gross Profit |
-4.78M | -178.00K | 60.08M | 97.31M | 24.05M | EBIT |
-20.50M | -14.72M | 33.55M | 70.88M | -78.61M | EBITDA |
-20.05M | -9.01M | 47.44M | 98.52M | -84.31M | Net Income Common Stockholders |
-19.44M | -8.23M | 6.95M | 7.98M | -61.73M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
82.64M | 102.43M | 128.78M | 129.00M | 50.54M | Total Assets |
122.48M | 146.87M | 181.30M | 194.44M | 137.52M | Total Debt |
9.80M | 9.00M | 11.20M | 15.00M | 15.16M | Net Debt |
-40.48M | -81.88M | -115.86M | -101.07M | -32.75M | Total Liabilities |
24.82M | 29.00M | 32.94M | 59.16M | 39.02M | Stockholders Equity |
40.05M | 50.62M | 61.06M | 52.78M | 42.74M |
Cash Flow | Free Cash Flow | |||
-21.64M | -7.56M | 34.85M | 73.61M | 27.66M | Operating Cash Flow |
-21.00M | -6.05M | 48.68M | 85.27M | 29.25M | Investing Cash Flow |
-20.54M | -7.91M | -581.00K | -9.52M | -207.00K | Financing Cash Flow |
4.50M | -13.95M | -41.92M | -13.89M | -20.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | HK$1.19B | 7.91 | 48.79% | ― | 48.83% | 11.99% | |
61 Neutral | $11.56B | 10.45 | -6.94% | 2.92% | 7.54% | -8.99% | |
53 Neutral | HK$1.41B | ― | -30.10% | ― | 130.71% | 51.92% | |
46 Neutral | HK$104.54M | ― | -0.21% | ― | -22.84% | -103.13% | |
40 Underperform | HK$25.80M | ― | -9.50% | ― | -58.07% | -331.12% | |
34 Underperform | HK$26.31M | ― | ― | -68.00% | 25.80% | ||
33 Underperform | €92.08M | ― | -48.55% | ― | 94428.16% | -88.74% |